During the past decade, Kreiskrankenhaus Radebeul conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kreiskrankenhaus Radebeul" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials, followed by "Jena University Hospital" with 2 trials sponsored, "Acotec Scientific Co., Ltd" with 1 trials sponsored, "III. Medizinische Klinik Mannheim" with 1 trials sponsored and "Straub Medical AG" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kreiskrankenhaus Radebeul" #1 collaborator was "Concept Medical Inc." with 2 trials as a collaborator, "CoreLab Black Forest" with 2 trials as a collaborator, "Center for Clinical Studies Jena" with 1 trials as a collaborator, "Center for Clinical Studies, University Hospital Jena" with 1 trials as a collaborator and "VascuScience GmbH" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Kreiskrankenhaus Radebeul" are "Lymphoma" (3 trials), "Peripheral Artery Disease" (3 trials), "Carotid Artery Stenosis" (1 trials), "Leukemia" (1 trials) and "Peripheral Arterial Disease" (1 trials). Many other conditions were trialed in "Kreiskrankenhaus Radebeul" in a lesser frequency.

Most popular intervention types in "Kreiskrankenhaus Radebeul" are "Biological" (4 trials), "Device" (4 trials), "Drug" (4 trials), "Radiation" (4 trials) and "Combination Product" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (4 trials), "radiation therapy" (4 trials), "doxorubicin hydrochloride" (3 trials), "filgrastim" (3 trials) and "prednisone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Kreiskrankenhaus Radebeul" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Kreiskrankenhaus Radebeul". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Kreiskrankenhaus Radebeul, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kreiskrankenhaus Radebeul, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".